Cargando…
Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure
Background: The inhibition of sodium-glucose co-transporter 2 (SGLT-2) has been shown to be beneficial in the treatment of diabetic and non-diabetic patients with heart failure. The underlying mechanisms are incompletely understood. The present prospective study investigates for the first time the e...
Autores principales: | Gotzmann, Michael, Henk, Pauline, Stervbo, Ulrik, Blázquez-Navarro, Arturo, Mügge, Andreas, Babel, Nina, Westhoff, Timm H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342830/ https://www.ncbi.nlm.nih.gov/pubmed/37445494 http://dx.doi.org/10.3390/jcm12134458 |
Ejemplares similares
-
beadplexr: reproducible and automated analysis of multiplex bead assays
por: Stervbo, Ulrik, et al.
Publicado: (2018) -
Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
por: Cinkilic, Okan, et al.
Publicado: (2022) -
Epitope similarity cannot explain the pre-formed T cell immunity towards structural SARS-CoV-2 proteins
por: Stervbo, Ulrik, et al.
Publicado: (2020) -
Inferior cellular and humoral immunity against Omicron and Delta variants of concern compared with SARS-CoV-2 wild type in hemodialysis patients immunized with 4 SARS-CoV-2 vaccine doses
por: Anft, Moritz, et al.
Publicado: (2022) -
Case report: SARS-CoV-2 specific T-cells are associated with myocarditis after COVID-19 vaccination with mRNA-1273
por: Stervbo, Ulrik, et al.
Publicado: (2023)